vs
Side-by-side financial comparison of Spire Global, Inc. (SPIR) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Spire Global, Inc. is the larger business by last-quarter revenue ($15.8M vs $12.6M, roughly 1.3× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -176.6%, a 427.3% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -26.9%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -32.6%).
Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.
SPIR vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.8M | $12.6M |
| Net Profit | $-28.0M | $31.5M |
| Gross Margin | 40.2% | — |
| Operating Margin | -164.1% | — |
| Net Margin | -176.6% | 250.7% |
| Revenue YoY | -26.9% | 24080.8% |
| Net Profit YoY | 42.7% | 250.9% |
| EPS (diluted) | $-0.85 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.8M | $12.6M | ||
| Q3 25 | $12.7M | $0 | ||
| Q2 25 | $19.2M | $0 | ||
| Q1 25 | $23.9M | $12.0K | ||
| Q4 24 | $21.7M | $52.0K | ||
| Q3 24 | $28.6M | $65.0K | ||
| Q2 24 | $25.4M | $114.0K | ||
| Q1 24 | $34.8M | $140.0K |
| Q4 25 | $-28.0M | $31.5M | ||
| Q3 25 | $-19.7M | $-7.4M | ||
| Q2 25 | $119.6M | $-1.7M | ||
| Q1 25 | $-20.7M | $-13.9M | ||
| Q4 24 | $-48.8M | — | ||
| Q3 24 | $-12.5M | $-17.1M | ||
| Q2 24 | $-16.6M | $-17.9M | ||
| Q1 24 | $-25.5M | $-12.7M |
| Q4 25 | 40.2% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 48.9% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 32.4% | — | ||
| Q3 24 | 44.5% | — | ||
| Q2 24 | 43.0% | — | ||
| Q1 24 | 26.5% | — |
| Q4 25 | -164.1% | — | ||
| Q3 25 | -166.1% | — | ||
| Q2 25 | -122.7% | — | ||
| Q1 25 | -106.5% | -122758.3% | ||
| Q4 24 | -144.1% | — | ||
| Q3 24 | -48.0% | -28604.6% | ||
| Q2 24 | -48.6% | -16720.2% | ||
| Q1 24 | -34.4% | -9987.1% |
| Q4 25 | -176.6% | 250.7% | ||
| Q3 25 | -155.3% | — | ||
| Q2 25 | 623.4% | — | ||
| Q1 25 | -86.5% | -115550.0% | ||
| Q4 24 | -225.2% | — | ||
| Q3 24 | -43.7% | -26380.0% | ||
| Q2 24 | -65.2% | -15668.4% | ||
| Q1 24 | -73.3% | -9049.3% |
| Q4 25 | $-0.85 | $0.56 | ||
| Q3 25 | $-0.61 | $-0.13 | ||
| Q2 25 | $3.72 | $-0.03 | ||
| Q1 25 | $-0.77 | $-0.25 | ||
| Q4 24 | $-1.93 | — | ||
| Q3 24 | $-0.50 | $-0.32 | ||
| Q2 24 | $-0.68 | $-0.33 | ||
| Q1 24 | $-1.17 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.8M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $112.9M | $59.0M |
| Total Assets | $211.0M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.8M | $40.3M | ||
| Q3 25 | $96.8M | $48.6M | ||
| Q2 25 | $117.6M | $31.2M | ||
| Q1 25 | $35.9M | $48.9M | ||
| Q4 24 | $19.2M | $52.9M | ||
| Q3 24 | $36.6M | $76.3M | ||
| Q2 24 | $45.8M | $63.5M | ||
| Q1 24 | $63.7M | $82.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $103.7M | — | ||
| Q4 24 | $103.1M | — | ||
| Q3 24 | $4.9M | — | ||
| Q2 24 | $4.9M | — | ||
| Q1 24 | $123.1M | — |
| Q4 25 | $112.9M | $59.0M | ||
| Q3 25 | $133.1M | $26.5M | ||
| Q2 25 | $149.2M | $32.8M | ||
| Q1 25 | $3.7M | $33.8M | ||
| Q4 24 | $-11.7M | $46.1M | ||
| Q3 24 | $30.8M | $65.5M | ||
| Q2 24 | $40.3M | $80.5M | ||
| Q1 24 | $52.5M | $96.2M |
| Q4 25 | $211.0M | $68.9M | ||
| Q3 25 | $224.3M | $54.2M | ||
| Q2 25 | $239.5M | $62.1M | ||
| Q1 25 | $208.8M | $77.7M | ||
| Q4 24 | $193.6M | $110.5M | ||
| Q3 24 | $224.2M | $135.2M | ||
| Q2 24 | $230.8M | $149.9M | ||
| Q1 24 | $252.3M | $167.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 27.92× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 2.35× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.3M | $-8.4M |
| Free Cash FlowOCF − Capex | $-16.2M | — |
| FCF MarginFCF / Revenue | -102.1% | — |
| Capex IntensityCapex / Revenue | 75.1% | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-92.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.3M | $-8.4M | ||
| Q3 25 | $-12.0M | $17.4M | ||
| Q2 25 | $-35.1M | $-17.7M | ||
| Q1 25 | $-8.4M | $-4.0M | ||
| Q4 24 | $-19.2M | $-23.4M | ||
| Q3 24 | $14.0M | $12.8M | ||
| Q2 24 | $-4.4M | $-18.7M | ||
| Q1 24 | $-8.8M | $5.9M |
| Q4 25 | $-16.2M | — | ||
| Q3 25 | $-20.4M | — | ||
| Q2 25 | $-38.7M | — | ||
| Q1 25 | $-17.3M | — | ||
| Q4 24 | $-24.3M | — | ||
| Q3 24 | $5.1M | — | ||
| Q2 24 | $-9.9M | — | ||
| Q1 24 | $-15.9M | — |
| Q4 25 | -102.1% | — | ||
| Q3 25 | -161.3% | — | ||
| Q2 25 | -201.7% | — | ||
| Q1 25 | -72.6% | — | ||
| Q4 24 | -112.2% | — | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | -39.0% | — | ||
| Q1 24 | -45.7% | — |
| Q4 25 | 75.1% | — | ||
| Q3 25 | 66.2% | — | ||
| Q2 25 | 18.8% | — | ||
| Q1 25 | 37.3% | — | ||
| Q4 24 | 23.5% | — | ||
| Q3 24 | 31.2% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 20.3% | — |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
